A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate hormone dynamics, pharmacokinetics, safety, and
efficacy of TAP-144-SR(6M) against TAP-144-SR(3M) in prostate cancer patients previously
treated with hormonal therapy.